Dopamine and hippocampus

April 3, 2014

Bruno Giros, PhD, a researcher at the Douglas Mental Health University Institute and a professor in the Department of Psychiatry at McGill University, has demonstrated, for the first time, the role that dopamine plays in a region of the brain called the hippocampus. Published in Biological Psychiatry, this discovery opens the door to a better understanding of psychiatric diseases, such as schizophrenia.

Dopamine is a neurotransmitter that plays a central role in , and many involve an imbalance in this chemical. What Bruno Giros has shown in particular is that dopamine is present in the hippocampus—the brain area associated with memory and learning—and that it plays a key role in this region.

"Our work helps us better understand some of the symptoms of schizophrenia for which the cause in the brain was unknown, particularly in the area of memory and learning. In a few years, this research could help researchers come up with new therapeutic approaches to improve these symptoms," explained Bruno Giros.

Dr. Giros is the Graham Boeckh Chair in Schizophrenia and the Canada Research Chair in Neurobiology of Mental Disorders. He is one of the world's leading scientists in the study and treatment of . In 1999, he created the Neurobiology and Psychiatry Laboratory at the Institut national de la santé et de la recherche médicale (INSERM) in France. He came to the Douglas Institute in 2008.

Explore further: Scientists unpack testosterone's role in schizophrenia

Related Stories

Jumping DNA in the brain may be a cause of schizophrenia

January 2, 2014

Stretches of DNA called retrotransposons, often dubbed "junk DNA", might play an important role in schizophrenia. In a study published today in the journal Neuron, a Japanese team revealed that LINE-1 retrotransposons are ...

New target explored for psychiatric drug development

January 29, 2014

(Medical Xpress)—In a surprising discovery, neuroscientists have found that a breakdown product of cholesterol in the brain may be a target for developing new drugs to treat schizophrenia and other mental illnesses.

Recommended for you

Men with anxiety are more likely to die of cancer, study says

September 20, 2016

Men over 40 who are plagued with the omnipresent of generalized anxiety disorder are more than twice as likely to die of cancer than are men who do not have the mental affliction, new research finds. But for women who suffer ...

Alcoholics may lack key enzyme

September 22, 2016

(HealthDay)—Alcoholics may lack an enzyme that would help them control their impulse to drink, a new study with rats suggests.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.